GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Results] 46 weeks on 1.7mg, full numbers, ask me anything boring — 63 comments in the full submission. View in context.
1.2k
c/cagrilintide·submitted 7 months ago by u/andres_dahlberg

[Results] 46 weeks on 1.7mg, full numbers, ask me anything boring

Questionbranch of 8 comments

I have had 21 orders now and I keep a table, so here is the honest summary rather than a vibe. Material has been consistent. Communication has not. Shipping has varied by about 18 days on nominally the same lane, which matters more in summer than in February. The independent number came back 97.9% against a claimed…

Read the full submission and all 63 comments →

This branch

8 comments, started 6 months ago
u/ledger_modMOD61 points·6 months ago

This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.

replysharereportpermalink
[removed]45 points·6 months ago

[removed by moderator]

replysharereportpermalink
u/crosspost_bot_no25 points·6 months ago

[removed by moderator]

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/zeynep_duarte16 points·6 months ago

CagriSema ratios in trials are fixed, do not extrapolate self-mixing

replysharereportpermalink
u/emil_agyeman11 points·6 months ago

Are we talking amylin or GLP-1 here?

replysharereportpermalink
u/hedda_aguirre73 points·6 months ago

Yeah, amylin is doing different work than GLP-1.

replysharereportpermalink
u/hugo_pires59 points·6 months ago·edited

Strongly agree. REDEFINE is phase 8, not final.

replysharereportpermalink
u/amara_halonen36 points·6 months ago

the mechanism is different, the side effect profile reflects it

replysharereportpermalink

← back to the whole thread

About c/cagrilintide

Amylin analog pharmacology and the CagriSema combination: why amylin and GLP-1 co-agonism produces a different satiety profile, the REDEFINE readouts, and the very limited pool of people handling cagrilintide as research material.

19kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/cagrilintide
c/cagrilintide rules
  1. Amylin is not a GLP-1. Posts conflating them get corrected.
  2. CagriSema ratios in trials are fixed-dose. Do not extrapolate to self-mixing.
  3. Not approved anywhere. Keep posts descriptive, not instructional.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/amylin_amyu/incretin_ivyu/ledger_mod
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →